Published in Cancer Weekly, June 10th, 2008
Phospholipid nanosomes are small, uniform liposomes manufactured utilizing SuperFluids(TM). SuperFluids(TM) are normally gases which, when compressed, exhibit enhanced solvation, penetration and expansive properties. These fluids are reverse-engineered to form phospholipid nanosomes for encapsulating and improving the delivery of protein therapeutics, vaccine antigens and sRNAi molecules as well as small molecule therapeutics and hydrophobic drugs such as...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.